Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

Similar Items

• β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL
  od: Nyirjesy, Sarah C, i dr.
  Izdano: (2018)
• Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis
  od: Kilberg, Marissa J, i dr.
  Izdano: (2020)
• DYSREGULATED INSULIN IN PANCREATIC INSUFFICIENT CYSTIC FIBROSIS WITH POST-PRANDIAL HYPOGLYCEMIA
  od: Kilberg, Marissa J, i dr.
  Izdano: (2019)
• Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy
  od: Kelly, Andrea, i dr.
  Izdano: (2019)
• Different β-cell secretory phenotype in non-obese compared to obese early type 2 diabetes
  od: Gudipaty, Lalitha, i dr.
  Izdano: (2020)